NCT04862559 is a NA clinical trial of NovaCross in Chronic Total Occlusion, sponsored by Nitiloop Ltd..

Who is sponsoring NCT04862559?

NCT04862559 is sponsored by Nitiloop Ltd..

What drugs are being tested in NCT04862559?

Interventions in NCT04862559: NovaCross.

What condition does NCT04862559 study?

NCT04862559 studies Chronic Total Occlusion.

Is NCT04862559 still recruiting?

NCT04862559 is currently completed. Last updated 28 April 2021.

Last reviewed 2021-04-28 · How we verify

NCT04862559

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Single Center Study to Evaluate the Safety of the NovaCross Microcatheter in Crossing Chronic Total Occlusions

Completed NA Last updated 28 April 2021

What this trial tests

NA trial testing NovaCross in Chronic Total Occlusion in 15 participants. Completed in 17 September 2017.

Timeline

1 February 2017

Primary endpoint
17 September 2017

17 September 2017

Quick facts

Lead sponsor	Nitiloop Ltd.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	15
Start date	1 February 2017
Primary completion	17 September 2017
Estimated completion	17 September 2017
Sites	1 location across Poland

Drugs / interventions tested

NovaCross

Conditions studied

Chronic Total Occlusion — all drugs for Chronic Total Occlusion →

Sponsor

Nitiloop Ltd.

Who can join

Adults 25 to 80, any sex, with Chronic Total Occlusion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is an open label, single-center, prospective, pivotal study in which the investigational device, NovaCross™ micro-catheter, will be tested in up to 15 patients scheduled to undergo CTO-PCI using an anterograde approach.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of NovaCross

Trials testing the same drug.

NCT02477579 — A Prospective, Multi-Center, Pivotal Study to Evaluate the Safety and Effectiveness of the NovaCross™ Micro-catheter in · NA · completed

Other recruiting trials for Chronic Total Occlusion

Currently open trials in the same condition.

NCT06137521 — Risk Factors and Outcomes in Coronary Chronic Total Occlusion · recruiting

Other Nitiloop Ltd. trials

Trials by the same sponsor.

NCT03717675 — Supplemental Study to Evaluate the Safety and Effectiveness of the NovaCross™ Micro-catheter · NA · completed
NCT02477579 — A Prospective, Multi-Center, Pivotal Study to Evaluate the Safety and Effectiveness of the NovaCross™ Micro-catheter in · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04862559 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nitiloop Ltd.
Last refreshed: 28 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04862559.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing